Showing results (51-60 of 851) with videos related to
Sort By:
Pageof 86
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Immunoglobulin m monoclonal gammopathy of undetermined significance and smoldering Waldenström macroglobulinemiaRobert A Kyle, Terry M Therneau, Angela Dispenzieri, et al.Cancer|October 10, 2013
Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategiesBrian L Burnette, Angela Dispenzieri, Shaji Kumar, et al.Blood|July 31, 2009
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myelomaCheng E Chee, Shaji Kumar, Dirk R Larson, et al.Cancer|November 20, 2009
Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myelomaEric W Schaefer, Shaji Kumar, Angela Dispenzieri, et al.Blood|March 28, 2012
Progression in smoldering Waldenstrom macroglobulinemia: long-term resultsRobert A Kyle, Joanne T Benson, Dirk R Larson, et al.The Lancet. Haematology|December 23, 2014
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort studyRobert A Kyle, Dirk R Larson, Terry M Therneau, et al.Experimental Hematology|March 19, 2008
R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cellsMichael P Kline, S Vincent Rajkumar, Michael M Timm, et al.Clinical Lymphoma, Myeloma & Leukemia|May 8, 2026
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025)Philippe Moreau, Shaji Kumar, Noopur S Raje, et al.Medical Oncology (Northwood, London, England)|December 26, 2009
Treatment of newly diagnosed multiple myeloma: advances in current therapyShaji KumarPageof 86